Contact FreedomWorks

111 K Street NE
Suite 600
Washington, DC 20002

  • Toll Free 1.888.564.6273
  • Local 202.783.3870
LISTEN NOWThe Freedom Files Podcast Episode 42: Jim LamonListen Here
Op-ed Placement

New FDA Commissioner Needs to Get in Line With the Rest of Trump’s Deregulation

BY Ken Cuccinelli

Democratic control of the House of Representatives and the departure of Food and Drug Administration Commissioner Scott Gottlieb is a key turning point in President Trump's first turn and should be seen as an opportunity for the Trump administration to double down on deregulation. Some of the greatest policy victories of the last two years have come from an expansion of freedom and opportunity as a result of executive agencies rolling back burdensome regulations. With more gridlock expected in Congress, the administration has the chance to place an increased focus on its successful deregulatory agenda.


Regulatory Action Center Review - January 23, 2019

Welcome to FreedomWorks Foundation’s second regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy and the American people by delivering regulatory news straight to FreedomWorks activists. Check back in two weeks for the next edition.